Latest US Food and Drug Administration Stories
PLANO, Texas, Nov. 19, 2014 /PRNewswire/ -- Argon Medical Devices, Inc.
DUBLIN, October 24, 2014 /PRNewswire/ -- - Increases Non GAAP diluted earnings per ADS growth guidance to the high thirty percent range for the full year (2014).
Experts team-up to help keep quality medicines available to those who need them TAMPA, Fla., Oct.
Key evaluation to inform the US Food and Drug Administration regulatory submission SYDNEY, Sept.
Pivotal Phase 3 Clinical Trial Targeted to Begin in First Half of 2015 PRINCETON, N.J., Sept. 17, 2014 /PRNewswire/ -- Soligenix, Inc.
Newly Acquired SGX301 Orphan Drug Candidate Being Evaluated for Treatment of Cutaneous T-Cell Lymphoma PRINCETON, N.J., Sept. 5, 2014 /PRNewswire/ -- Soligenix, Inc.
LISBON, Portugal, July 31, 2014 /PRNewswire/ -- Hovione today announced that its API plant in Cork, Ireland has successfully passed a pre-approval inspection by the US
DUBLIN, July 18, 2014 /PRNewswire/ -- NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (IN WHOLE OR IN PART) IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE
FREDERICK, Md., July 16, 2014 /PRNewswire/ -- ImQuest Pharmaceuticals was recently notified by the US Food and Drug Administration of the approval of its Investigational New Drug (IND) application
Cell-culture technology is a modern alternative to manufacture influenza vaccines without chicken eggs, with potential to rapidly respond to a pandemic BASEL, Switzerland, June 16, 2014